rSIFN-co in Combination With Total Neo-adjuvant Therapy in Subjects With Mid-low Locally Advanced Rectal Cancer
Clinical trial NCT07662278 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07662278
- Sponsor
- Sichuan Huiyang Life Science and Technology Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-01
- Primary completion
- 2030-01-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.